Clinical Trial

Appropriate Dosage of Vasopressor in Neonates and Infants

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
In this study, the investigators will evaluate cerebral blood flow before and after drug infusion using ultrasound to suggest blood pressure criteria and dosage of ephedrine, a vasopressor, to maintain adequate cerebral blood flow in neonates and infants undergoing surgery and anesthesia.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-02-05.
Trial Details
NCT Number NCT06257316
Lead Sponsor Seoul National University Hospital
Conditions Hypotension, Neonatal Hypotension, Intraoperative Complications
Enrollment 132 participants
Start Date 2024-02-15
Primary Completion 2027-02-28 (estimated)
Study Completion 2028-02-28 (estimated)
Updated on ClinicalTrials.gov 2024-02-15